Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP150100046
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Funded Activity Details
Start Date: 06-2016
End Date: 06-2019
Funding Scheme: Linkage Projects
Funding Amount: $488,235.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Infectious Agents | Veterinary Immunology | Microbiology
ANZSRC Socio-Economic Objective (SEO)
Control of Animal Pests, Diseases and Exotic Species in Forest and Woodlands Environments | Flora, Fauna and Biodiversity of environments not elsewhere classified | Veterinary Biological Preventatives (e.g. Vaccines) |
